David T. Rubin, MD, from the University of Chicago, is the chair of the Advances in Inflammatory Bowel Diseases Regional Meeting in Chicago, Illinois. In this podcast, he provides highlights of the upcoming...
In this commentary, Nirupama N. Bonthala, MD, from Cedars-Sinai Medical Center, highlights important topics gastroenterologists can address with patients with IBD who are pregnant or considering pregnancy.
...
Marla Dubinsky, MD, from Icahn School of Medicine at Mount Sinai Hospital, discusses fertility among women with IBD, why managing these patients may not be as simple as it seems, and more.
At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
Stephen Hanauer, MD, from Northwestern Medicine, highlights breakthroughs in autoimmune diseases, the upcoming Interdisciplinary Autoimmune Summit (IAS), and more.
In this commentary, Dr Miguel Regueiro from Cleveland Clinic highlights potential adverse effects of biologics that should be considered when selecting the ideal treatment for a patient with inflammatory...
Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.
Dr Mark Deneau from University of Utah Health discusses the current management of pediatric inflammatory bowel disease and primary sclerosing cholangitis, the importance of identifying patients for...
Dr Sunanda Kane, president of the American College of Gastroenterology, discusses current guidelines for managing severe ulcerative colitis, controversies surrounding rescue treatment, and more.
